Stephane Chatonsky

Stephane Chatonsky is a highly accomplished individual with a diverse educational background and extensive experience in various organizations.

Stephane holds a Master of Business Administration in Finance from The Wharton School and has also pursued studies in Management and Education at Insead, Education at Harvard Business School, and Bachelors in Economics and Business Analytics at Essec | Centralesupélec.

Throughout his career, Stephane has held key positions in several organizations, including being the Co-Founder and Managing Director at Ivest, Non-Executive Director at 4Cyte Pathology, Executive Chairman and Investor at Prospection Au, Chairman of Syndicate at The CEO Institute, among others.

His contributions span across advisory roles, board memberships, professorships, and executive positions in companies like Thinxtra, Ebev, Leapfrog Investments, Spark New Zealand, and Macquarie Group.

Stephane's expertise includes finance, mergers and acquisitions, investments, venture capital, technology investment banking, and strategic advisory, making him a valuable asset in the business and academic spheres.